WHO international standard for SARS-CoV-2 antibodies to determine markers of protection

Documents similaires

• Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China: The first National Standard calibration traceability to the WHO International Standard
  par: Lidong Guan, et autres
  Publié: (2023-02-01)
• WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community
  par: Ivana Knezevic, PhD, et autres
  Publié: (2022-03-01)
• Standardization of SARS-CoV-2 Nucleic Acid Amplification Techniques by Calibration and Quantification to the First WHO International Standard for SARS-CoV-2 RNA
  par: Jolanda J. C. Voermans, et autres
  Publié: (2023-01-01)
• Maritime Public Health Cross Border Cooperation: Principality of Monaco and Italian Liguria Health Port Authority Best Practices
  par: Antonello Campagna, et autres
  Publié: (2022-12-01)
• SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
  par: Jeewandara, C, et autres
  Publié: (2021)